Article info

Original research
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2

Authors

  1. Correspondence to Adam N Rosenthal, Gynaecological Oncology, University College London EGA Institute for Women's Health Department of Women's Cancer, London, London, UK; adam.rosenthal{at}ucl.ac.uk
View Full Text

Citation

Philpott S, Raikou M, Manchanda R, et al
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2

Publication history

  • Received June 7, 2022
  • Accepted August 17, 2022
  • First published November 1, 2022.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.